Galia Inbar - 15 Aug 2021 Form 3 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Signature
/s/ Dov Bergwerk as attorney-in-fact for Galia Inbar
Issuer symbol
TEVA
Transactions as of
15 Aug 2021
Net transactions value
$0
Form type
3
Filing time
19 Aug 2021, 16:02:29 UTC
Next filing
02 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TEVA Ordinary Shares 4,828 15 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TEVA Restricted Share Units 15 Aug 2021 Ordinary Shares 22,842 Direct F1, F2, F3
holding TEVA Restricted Share Units 15 Aug 2021 Ordinary Shares 14,485 Direct F1, F3, F4
holding TEVA Stock Options (Right to Buy) 15 Aug 2021 Ordinary Shares 3,450 $19.16 By Spouse F1, F5
holding TEVA Stock Options (Right to Buy) 15 Aug 2021 Ordinary Shares 2,255 $34.70 By Spouse F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Restricted share units were granted on March 5, 2021, with 5,710 vesting on each of March 5, 2022, March 5, 2023 and March 5, 2024 and 5,712 vesting on March 5, 2025.
F3 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F4 Restricted share units were granted on February 28, 2020, with 4,828 vesting on each of February 28, 2022 and February 28, 2023 and 4,829 vesting on February 28, 2024.
F5 Stock Options were granted on March 3, 2018, with 1,150 vested on each of March 2, 2019, March 2, 2020 and March 2, 2021.
F6 Stock Options were granted on March 3, 2017, with 563 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 566 vested on March 3, 2021.

Remarks:

EVP, Chief Human Resources Officer and Head of Global Communications, Brand and ESG